Adel A Rashad Selected Research

sulfide quinone reductase

1/2022

Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adel A Rashad Research Topics

Disease

8	Infections 06/2021 - 07/2013
1	Heart Failure 01/2022
1	COVID-19 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	HIV Infections (HIV Infection) 01/2016
1	African Trypanosomiasis (Nagana) 05/2014

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 06/2021 - 01/2016
4	TriazolesIBA 06/2021 - 01/2016
3	Antiviral Agents (Antivirals)IBA 12/2020 - 09/2015
2	Sulfhydryl Compounds (Thiols)IBA 06/2021 - 12/2015
1	sulfide quinone reductaseIBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2020
1	Piroxicam (Feldene)FDA LinkGeneric 12/2020
1	Biological ProductsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2016
1	Dextrans (Dextran)FDA Link 01/2016
1	LigandsIBA 01/2016
1	DisulfidesIBA 12/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2015
1	Pharmaceutical PreparationsIBA 05/2014
1	Viral Envelope ProteinsIBA 07/2013